Tue, May 8, 2018
Mon, May 7, 2018
Fri, May 4, 2018
Thu, May 3, 2018
Wed, May 2, 2018
Tue, May 1, 2018
Mon, April 30, 2018
Fri, April 27, 2018
Thu, April 26, 2018

Andrew Schenker Maintained (THC) at Sell with Increased Target to $24 on, May 2nd, 2018


//stocks-investing.news-articles.net/content/201 .. with-increased-target-to-24-on-may-2nd-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Andrew Schenker of Morgan Stanley, Maintained "Tenet Healthcare Corporation" (THC) at Sell with Increased Target from $16 to $24 on, May 2nd, 2018.

Andrew has made no other calls on THC in the last 4 months.



There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gary Lieberman of "Wells Fargo" Maintained at Hold with Increased Target to $22 on, Wednesday, February 28th, 2018


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Gary Taylor of "JP Morgan" Maintained at Sell with Increased Target to $18 on, Monday, March 5th, 2018
  • Ralph Giacobbe of "Citigroup" Maintained at Strong Buy with Increased Target to $27 on, Thursday, March 1st, 2018
  • John Ransom of "Raymond James" Upgraded from Hold to Buy on, Wednesday, February 28th, 2018

Publication Contributing Sources